Communiqués de Presse - Page 20 sur 74 - France Biotech

BIOMUNEX a French company specialized in immunotherapy, presents the latest preclinical results on its disruptive MAIT cell redirection approach for cancer treatment at the 2023 AACR1 Annual Meeting

ALGOTHERAPEUTIX Announces First Patients Dosed in US and European Arms of Phase II Clinical Trial of ATX01 in Rare Disease Erythromelalgia

ALGENSCRIBE : ERS Genomics & AlgenScribe Enter Into CRISPR/Cas9 Licensing Agreement

AGS THERAPEUTICS Named among Business Worldwide Magazines 20 Most Innovative Companies to Watch in 2023

4P-PHARMA : Didier Landais est nommé CEO de 4P-Pharma

Révolution & essor des dispositifs médicaux numériques à visées thérapeutiques : comment poser les fondements et accompagner cette filière émergente en France ?